+ Follow AVENTIS Tag
AVENTIS
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 663612
[Title] => Japan halts vaccines after deaths of 4 children
[Summary] => Japan has temporarily stopped using vaccines from U.S. drugmaker Pfizer Inc. and Sanofi-Aventis SA of France while it investigates the deaths of four children who were inoculated, the health ministry said Monday.
[DatePublished] => 2011-03-07 16:11:44
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[1] => Array
(
[ArticleID] => 627679
[Title] => Fish oil to benefit consumers
[Summary] => Leading pharmaceutical company Sanofi-Aventis Philippines introduces a new dietary supplement, Cenovis Fish Oil, an all-natural supplement that contains the rich, concentrated goodness of Omega 3 DHA & EPA essential fatty acids that have numerous beneficial effects on the body, from helping maintain brain health and good skin to its anti-cancer and anti-inflammatory properties.
[DatePublished] => 2010-11-08 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[2] => Array
(
[ArticleID] => 273897
[Title] => Greenpeace raises alarm on RP market food products
[Summary] => Food products sold in local markets and corn being grown in farms in the country may possibly be contaminated, according to the admission of a Swiss biotechnology company that mistakenly sold hundreds of tons of the wrong genetically engineered (GE) maize to the United States over the past four years.
[DatePublished] => 2005-04-14 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1097177
[AuthorName] => Katherine Adraneda
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[3] => Array
(
[ArticleID] => 246270
[Title] => Breast cancer drug boosts survival
[Summary] => At least 1,500 lives could be saved every year if a drug used to treat terminal breast cancer cases is given early in the disease.
The Breast Cancer International Research Group (BCIRG) said docetaxel (distributed by Aventis Pharma Inc.) significantly improved the survival rate of women with early-stage breast cancer and reduced their risk of a relapse compared with a standard treatment. This implies that docetaxel is a potential life-saver and should not only be used in terminally ill patients to buy extra time.
[DatePublished] => 2004-04-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[4] => Array
(
[ArticleID] => 240769
[Title] => Who will pay for the damage?
[Summary] => Environmental groups are increasingly getting worried. While more nations are adopting genetically engineered biotechnology, there is no system in place that answers the issue of liability and redress in cases of genetically modified organisms (GMO) damage.
[DatePublished] => 2004-02-29 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1704647
[AuthorName] => Rocel Felix
[SectionName] => Agriculture
[SectionUrl] => agriculture
[URL] =>
)
[5] => Array
(
[ArticleID] => 204783
[Title] => Drugs return as trypanosomiasis reemerges
[Summary] => The approval of the cosmetic formulation of eflornithine encouraged the reintroductions of its intravenous formulation and of nifurtimox, both used to treat African trypanosomiasis it was reported at an international conference on emerging infectious diseases sponsored by the Centers for Disease Control and Prevention. The production of both drugs had been halted when sleeping sickness was almost eradicated in the 1960s and surveillance and treatment programs were dismantled during subsequent civil unrest and wars in central Africa.
[DatePublished] => 2003-05-04 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[6] => Array
(
[ArticleID] => 85006
[Title] => Vitarich harnesses experience of 2 feed giants
[Summary] => Vitarich Corp.’s partnership agreement with BOCM PAULS and Aventis has harnessed the expertise of two of the world’s biggest feed manufacturers, giving the Vitarich Research Center full time access to the vast experience and high technology capabilities of the two firms.
[DatePublished] => 2001-07-22 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Agriculture
[SectionUrl] => agriculture
[URL] =>
)
[7] => Array
(
[ArticleID] => 100764
[Title] => Merger creates a leading supplier
[Summary] =>
The merger of the parent companies of AgrEvo Environmental Health and
Rhone-Poulenc has created a worldwide leader in the production and supply of
active ingredients and concentrates that are found in many of the world's best
known consumer pest control products.
The new entity is called Aventis Environmental Science, a separate business
line of Aventis CropScience SA that was created in December last year from the
merger between Hoechst AG (Germany) and Rhone-Poulenc SA (France).
Albert Evangelista, manager of Aventis Environmental Science in the
Philippines, will lead the
[DatePublished] => 2000-02-14 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[8] => Array
(
[ArticleID] => 101544
[Title] => Aventis launches two companies in RP
[Summary] =>
Aventis SA, a world leader in life sciences, launched Monday two companies in
the Philippines that represent its core business areas: pharmaceuticals and
agriculture.
Launched in a press conference at the Skytop Hotel International Manila were
Aventis CropScience Philippines, Inc. and Aventis Pharma, Inc.
Among the guests who attended the press launch were French Ambassador Gilles
Chouraqui together with the first secretary, commercial, of the German Embassy,
Axel Goehner, and business associates of the two companies.
Clive J.
[DatePublished] => 2000-02-03 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
)
)
abtest
November 8, 2010 - 12:00am
February 14, 2000 - 12:00am
February 3, 2000 - 12:00am
